Posts in Publications

ScreenIn3D technology published in new Nature article

October 26th, 2018 Posted by Publications 0 thoughts on “ScreenIn3D technology published in new Nature article”

Performing drug screening of tissue derived from cancer patient biopsies using physiologically relevant 3D tumour models presents challenges due to the limited amount of available cell material. Here, we present a microfluidic platform that enables drug screening of cancer cell-enriched multicellular spheroids derived from tumour biopsies, allowing extensive anticancer compound screening prior to treatment. (more…)

Cancer drug screening: the historical perspective

July 21st, 2018 Posted by Publications 0 thoughts on “Cancer drug screening: the historical perspective”

Chemotherapy with cytotoxic and growth inhibitory drugs have played an important role in cancer therapy, used either alone or in combination with other treatment modalities such as surgery, radiation or biological therapy. Chemotherapy, in most instances, was the only alternative treatment for metastatic cancer – mainly given as drug combinations…

(more…)

Beyond Limitations: New Microfluidics Platform for Cancer Drug Screening and Profiling

May 29th, 2018 Posted by Publications 0 thoughts on “Beyond Limitations: New Microfluidics Platform for Cancer Drug Screening and Profiling”

High-attrition rates during clinical development of new cancer therapies still persist. A new 3D ex vivo microfluidics platform shall now enhance cancer drug screening and early development process by creating cancer models which predict clinical outcomes with significantly increased reliability.

Read the full article

Subscribe to Blog

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Our Company
Follow Us

 

© Copyright AMS Biotechnology (Ltd) / University of Strathclyde / ScreenIn3D. All rights reserved 2018.